| For: | Manojlovic N, Savic G, Nikolic B, Rancic N. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy. World J Clin Cases 2022; 10(3): 899-918 [PMID: 35127905 DOI: 10.12998/wjcc.v10.i3.899] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i3/899.htm |
| Number | Citing Articles |
| 1 |
Zoltan Herold, Magdolna Herold, Gyongyver Szentmartoni, Reka Szalasy, Julia Lohinszky, Aniko Somogyi, Attila Marcell Szasz, Magdolna Dank. Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study. Medical Sciences 2025; 13(3): 108 doi: 10.3390/medsci13030108
|
| 2 |
Valeria da Costa, Teresa Freire. Advances in the Immunomodulatory Properties of Glycoantigens in Cancer. Cancers 2022; 14(8): 1854 doi: 10.3390/cancers14081854
|
| 3 |
Hong‐Bo Ji, Bo Qian, Jian‐Jun Hu, Wei Qi, Zi‐Gang Che. Use of Dynamic Contrast‐Enhanced Magnetic Resonance Imaging Combined With Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19‐9 in Predicting Colorectal Cancer Liver Metastasis. Journal of Clinical Ultrasound 2025; 53(4): 612 doi: 10.1002/jcu.23917
|
| 4 |
Ya-Nan Li, Yang Wu, Feng-Wen Deng, Ying Lu, Guo-Bin Song, Lin Xiang, Tian Peng, Xue-Xin Cheng, Hou-Qun Ying. Cancer-derived inflammation is associated with bevacizumab resistance and inferior clinical outcomes in patients with metastatic colorectal cancer. Therapeutic Advances in Medical Oncology 2026; 18 doi: 10.1177/17588359251411086
|
| 5 |
Cai-Qiong Zhong, Ning-Bo Zhang, Jian Zhu. Prognostic prediction for colorectal cancer patients undergoing chemotherapy using PIV, FAR, and CONUT score. World Chinese Journal of Digestology 2025; 33(5): 373 doi: 10.11569/wcjd.v33.i5.373
|
